| SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer P Mu, Z Zhang, M Benelli, WR Karthaus, E Hoover, CC Chen, ... Science 355 (6320), 84-88, 2017 | 885 | 2017 |
| A combinatorial strategy for treating KRAS-mutant lung cancer E Manchado, S Weissmueller, JP Morris, CC Chen, R Wullenkord, ... Nature 534 (7609), 647-651, 2016 | 410 | 2016 |
| BRD4 connects enhancer remodeling to senescence immune surveillance N Tasdemir, A Banito, JS Roe, D Alonso-Curbelo, M Camiolo, ... Cancer discovery 6 (6), 612-629, 2016 | 324* | 2016 |
| NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination M Ruscetti, J Leibold, MJ Bott, M Fennell, A Kulick, NR Salgado, CC Chen, ... Science 362 (6421), 1416-1422, 2018 | 291 | 2018 |
| α-Ketoglutarate links p53 to cell fate during tumour suppression JP Morris IV, JJ Yashinskie, R Koche, R Chandwani, S Tian, CC Chen, ... Nature 573 (7775), 595-599, 2019 | 217 | 2019 |
| DNAJB1–PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma ER Kastenhuber, G Lalazar, SL Houlihan, DF Tschaharganeh, T Baslan, ... Proceedings of the National Academy of Sciences 114 (50), 13076-13084, 2017 | 147 | 2017 |
| The SS18-SSX oncoprotein hijacks KDM2B-PRC1. 1 to drive synovial sarcoma A Banito, X Li, AN Laporte, JS Roe, F Sanchez-Vega, CH Huang, ... Cancer cell 33 (3), 527-541. e8, 2018 | 132 | 2018 |
| MAT2A inhibition blocks the growth of MTAP-deleted cancer cells by reducing PRMT5-dependent mRNA splicing and inducing DNA damage P Kalev, ML Hyer, S Gross, Z Konteatis, CC Chen, M Fletcher, M Lein, ... Cancer Cell, 2021 | 121 | 2021 |
| Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation Z Zhang, C Zhou, X Li, SD Barnes, S Deng, E Hoover, CC Chen, YS Lee, ... Cancer cell 37 (4), 584-598. e11, 2020 | 108 | 2020 |
| A gain-of-function p53-mutant oncogene promotes cell fate plasticity and myeloid leukemia through the pluripotency factor FOXH1 E Loizou, A Banito, G Livshits, YJ Ho, RP Koche, FJ Sánchez-Rivera, ... Cancer discovery 9 (7), 962-979, 2019 | 68 | 2019 |
| Vitamin B6 addiction in acute myeloid leukemia CC Chen, B Li, SE Millman, C Chen, X Li, JP Morris, A Mayle, YJ Ho, ... Cancer Cell 37 (1), 71-84. e7, 2020 | 58 | 2020 |
| Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis Z Zhao, CC Chen, CD Rillahan, R Shen, T Kitzing, ME McNerney, ... Nature genetics 47 (5), 539-543, 2015 | 48 | 2015 |
| Onco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma CH Huang, CJ Kuo, SS Liang, SW Chi, E Hsi, CC Chen, KT Lee, ... BBA clinical 3, 205-213, 2015 | 47 | 2015 |
| Impact of RNA-guided technologies for target identification and deconvolution M Fennell, Q Xiang, A Hwang, C Chen, CH Huang, CC Chen, R Pelossof, ... Journal of biomolecular screening 19 (10), 1327-1337, 2014 | 26 | 2014 |
| MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer C Zhu, YM Soto-Feliciano, JP Morris, CH Huang, RP Koche, Y Ho, ... Elife 12, e80854, 2023 | 6 | 2023 |
| A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets X Li, CH Huang, FJ Sánchez-Rivera, MC Kennedy, DF Tschaharganeh, ... Proceedings of the National Academy of Sciences 119 (17), e2110557119, 2022 | 5 | 2022 |
| Pancreatic Cancer JP Morris IV, JJ Yashinskie, R Koche, R Chandwani, S Tian, CC Chen | 1 | 2009 |
| Timing of treatment shapes the path to androgen receptor signaling inhibitor resistance in prostate cancer E Lee, Z Zhang, CC Chen, D Choi, ACA Rivera, E Linton, Y Ho, J Love, ... bioRxiv, 2024.03. 18.585532, 2024 | | 2024 |
| Abstract NG06: CHD1-loss confers AR targeted therapy resistance via promoting cancer heterogeneity and lineage plasticity Z Zhang, C Zhou, X Li, S Barnes, S Deng, E Hoover, CC Chen, YS Lee, ... Cancer Research 80 (16_Supplement), NG06-NG06, 2020 | | 2020 |
| Targeted therapy-induced senescence enhances immune surveillance of KRAS mutant lung cancers M Ruscetti, J Leibold, MJ Bott, M Shields, CC Chen, M Fennell, HC Chen, ... Cancer Research 78 (10 Sup), 2018 | | 2018 |
Chun-Hao HuangPostdoctoral Fellow, Jennifer Doudna Lab, UC BerkeleyVerified email at berkeley.edu
